MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary

被引:77
作者
Lee, Cheng-Han
Subramanian, Subbaya
Beck, Andrew H.
Espinosa, Inigo
Senz, Janine
Zhu, Shirley X.
Huntsman, David
van de Rijn, Matt
Gilks, C. Blake
机构
[1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver General Hospital, Vancouver, BC
[2] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
[3] Department of Pathology, Standford University Medical Center, Standford, CA
[4] Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC
来源
PLOS ONE | 2009年 / 4卷 / 10期
关键词
FALLOPIAN-TUBE; EXPRESSION PROFILES; GENE-EXPRESSION; NEW-MODEL; CANCER; P53; CELL; IDENTIFICATION; TUMORIGENESIS; ACCUMULATION;
D O I
10.1371/journal.pone.0007314
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: MicroRNAs (miRNA) are 20,25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically or in the setting of BRCA1/2 syndromes. Little is known regarding the miRNA expression profiles of high grade serous carcinoma in relation to BRCA1/2 status, and compared to normal tubal epithelium, the putative tissue of origin for high grade serous carcinomas. Methodology/Principal Findings: Global miRNA expression profiling was performed on a series of 33 high grade serous carcinomas, characterized with respect to BRCA1/2 status ( mutation, epigenetic silencing with loss of expression or normal), and with clinical follow-up, together with 2 low grade serous carcinomas, 2 serous borderline tumors, and 3 normal fallopian tube samples, using miRNA microarrays ( 328 human miRNA). Unsupervised hierarchical clustering based on miRNA expression profiles showed no clear separation between the groups of carcinomas with different BRCA1/2 status. There were relatively few miRNAs that were differentially expressed between the genotypic subgroups. Comparison of 33 high grade serous carcinomas to 3 normal fallopian tube samples identified several dysregulated miRNAs (false discovery rate <5%), including miR-422b and miR-34c. Quantitative RT-PCR analysis performed on selected miRNAs confirmed the pattern of differential expression shown by microarray analysis. Prognostically, lower level miR-422b and miR-34c in high grade serous carcinomas were both associated with decreased disease-specific survival by Kaplan-Meier analysis (p<0.05). Conclusions/Significance: High grade serous ovarian carcinomas with and without BRCA1/2 abnormalities demonstrate very similar miRNA expression profiles. High grade serous carcinomas as a group exhibit significant miRNA dysregulation in comparison to tubal epithelium and the levels of miR-34c and miR-422b appear to be prognostically important.
引用
收藏
页数:11
相关论文
共 61 条
[1]   Downregulation of microRNAs-143 and-145 in B-cell malignancies [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Kitade, Yukio ;
Kinoshita, Tomohiro ;
Naoe, Tomoki .
CANCER SCIENCE, 2007, 98 (12) :1914-1920
[2]  
Akao Y, 2006, ONCOL REP, V16, P845
[3]  
Asangani I. A., 2007, ONCOGENE
[4]   Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues [J].
Bandres, E. ;
Cubedo, E. ;
Agirre, X. ;
Malumbres, R. ;
Zarate, R. ;
Ramirez, N. ;
Abajo, A. ;
Navarro, A. ;
Moreno, I. ;
Monzo, M. ;
Garcia-Foncillas, J. .
MOLECULAR CANCER, 2006, 5 (1)
[5]   A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[6]   Cancer of the ovary [J].
Cannistra, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2519-2529
[7]   Nasopharyngeal carcinoma: molecular biomarker discovery and progress [J].
Cho, William Chi-shing .
MOLECULAR CANCER, 2007, 6 (1)
[8]   Post-analysis follow-up and validation of microarray experiments [J].
Chuaqui, RF ;
Bonner, RF ;
Best, CJM ;
Gillespie, JW ;
Flaig, MJ ;
Hewitt, SM ;
Phillips, JL ;
Krizman, DB ;
Tangrea, MA ;
Ahram, M ;
Linehan, WM ;
Knezevic, V ;
Emmert-Buck, MR .
NATURE GENETICS, 2002, 32 (Suppl 4) :509-514
[9]  
Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161
[10]   MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth [J].
Corney, David C. ;
Flesken-Nikitin, Andrea ;
Godwin, Andrew K. ;
Wang, Wei ;
Nikitin, Alexander Yu. .
CANCER RESEARCH, 2007, 67 (18) :8433-8438